LVM Capital Management shed 16,096 shares valued at $2.58 million. LVM now holds 40,603 ICON shares valued at $5.91 million. ICON is a mid-sized position for LVM, now representing 0.61% of the fund.

Provides clinical development services, including early and late-phase trials, patient recruitment, medical imaging, laboratory services, and regulatory consulting, primarily for the pharmaceutical, ...

Stock price: $147.59 as of July 8, 2025; one-year change: (54%); underperformed S&P 500 by 65.9 percentage points over the past year. No dividend; forward P/E ratio is 11.1; EV/EBITDA (LTM) is 10.1.